Fig. 2.
Distribution of the occurrence of any adverse event reported by MS patients following a third dose of BNT162b2 COVID-19 vaccination, across age and EDSS.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.